Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.
Authors and Affiliations
Les Clayes sous Bois, France
Gérard Emilien
Paris, France
Cécile Durlach
Department of Medicine and the Division of Aging, Harvard Medical School, Massachusetts General Hospital Geriatric Medicine Unit, Boston, USA
Kenneth Lloyd Minaker
Division of Geriatric Medicine Karolinska Institute, B84 Huddinge University Hospital, Huddinge, Sweden
Bengt Winblad
McGill Centre for Studies in Aging, McGill University, Verdun, Canada
Serge Gauthier
Laboratory of Pharmacology and Department of Neurology Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium
